Interim Guidance on Clinical Management and IPC for monkeypox in children, adults and special population groups

13 June, 2022

Dear HIFA and CHIFA colleagues,

The message below is forwarded from WHO.


Dear Colleagues,

Find below the link to the just published Interim guidance on the Clinical management & IPC for Monkeypox disease. It provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox.

It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.

Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022 (

Please share within your networks.

Kind regards,

Clinical management and IPC team


Join HIFA:

Join CHIFA (child health and rights):

Neil Pakenham-Walsh, Global Coordinator HIFA,

Global Healthcare Information Network: Working in official relations with WHO